Katharina Sophia Volz is the CEO of OccamzRazor, a San Francisco-based startup she founded in 2016 to find treatments for Parkinson’s disease using machine learning.
She studied biosciences at Harvard University. In 2015, she become the first researcher to receive a PhD in stem cell biology and regenerative medicine from Stanford University, completing her degree in a record time of two and a half years. During her PhD, she discovered the type of stem cells that can grow into coronary arteries, a breakthrough that can lead to new treatments for heart disease. In 2017, she made the Forbes 30 under 30 list in the science category.
Access to Expo and Startup Village
Access to networking areas
Access to event app